+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07185061

Study of Personalized Acoustic Stimulation to Treat Chronic Tinnitus Lasting Over Six Months

Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2025-09-22

200

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Chronic tinnitus is the perception of sound without any external source lasting six months or more, affecting a significant portion of the global population. It often disrupts hearing and daily life, with many patients requiring medical treatment. Researchers are exploring a new approach called Active Tinnitus Stimulation Therapy ATST, which targets brain mechanisms involved in tinnitus, aiming to reduce abnormal neuronal activity through personalized acoustic stimulation. The study evaluates the use of acoustic stimulation tailored to each patients hearing loss and tinnitus features. This device-generated therapy converts specific sound signals into electrical impulses that modulate auditory pathways and neurons. The therapy is adjusted based on patient responses to find the most comfortable sound range. The intervention period lasts 12 weeks, focusing on active neuromodulation to reduce tinnitus perception. Participants will undergo assessments including the Tinnitus Handicap Inventory, anxiety, depression, and sleep quality scales from enrollment through the 12-week treatment period. Researchers will monitor changes in tinnitus impact and related symptoms. The study is designed to gather evidence on the effectiveness of this acoustic stimulation intervention in managing chronic tinnitus symptoms over the treatment duration.

CONDITIONS

Brief Title

Interventional Treatment of Chronic Tinnitus With Acoustic Stimulation

Research Team

L

Lei Cheng, PhD,MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here